Sudhir Diwan
Lenox Hill Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Sudhir Diwan.
Neuromodulation | 2012
Timothy R. Deer; Joshua Prager; Robert M. Levy; James P. Rathmell; Eric Buchser; Allen W. Burton; David Caraway; Michael Cousins; José De Andrés; Sudhir Diwan; Michael A. Erdek; Eric Grigsby; Marc A. Huntoon; Marilyn S. Jacobs; Philip Kim; Krishna Kumar; Michael Leong; Liong Liem; Gladstone McDowell; Sunil Panchal; Richard Rauck; Michael Saulino; B. Todd Sitzman; Peter S. Staats; Michael Stanton-Hicks; Lisa Stearns; Mark T. Wallace; K. Dean Willis; William W. Witt; Tony L. Yaksh
Introduction: The use of intrathecal (IT) infusion of analgesic medications to treat patients with chronic refractory pain has increased since its inception in the 1980s, and the need for clinical research in IT therapy is ongoing. The Polyanalgesic Consensus Conference (PACC) panel of experts convened in 2000, 2003, and 2007 to make recommendations on the rational use of IT analgesics based on preclinical and clinical literature and clinical experiences.
Neuromodulation | 2014
Timothy R. Deer; Nagy Mekhail; David A. Provenzano; Jason E. Pope; Elliot S. Krames; Michael Leong; Robert M. Levy; David Abejón; Eric Buchser; Allen W. Burton; Asokumar Buvanendran; Kenneth D. Candido; David Caraway; Michael Cousins; Mike J. L. DeJongste; Sudhir Diwan; Sam Eldabe; Kliment Gatzinsky; Robert D. Foreman; Salim M. Hayek; Philip Kim; Thomas M. Kinfe; David Kloth; Krishna Kumar; Syed Rizvi; Shivanand P. Lad; Liong Liem; Bengt Linderoth; S. Mackey; Gladstone McDowell
The Neuromodulation Appropriateness Consensus Committee (NACC) of the International Neuromodulation Society (INS) evaluated evidence regarding the safety and efficacy of neurostimulation to treat chronic pain, chronic critical limb ischemia, and refractory angina and recommended appropriate clinical applications.
Neuromodulation | 2014
Timothy R. Deer; Nagy Mekhail; David A. Provenzano; Jason E. Pope; Elliot S. Krames; Michael Leong; Robert M. Levy; David Abejón; Eric Buchser; Allen W. Burton; Asokumar Buvanendran; Kenneth D. Candido; David Caraway; Michael Cousins; Mike J. L. DeJongste; Sudhir Diwan; Sam Eldabe; Kliment Gatzinsky; Robert D. Foreman; Salim M. Hayek; Philip Kim; Thomas M. Kinfe; David Kloth; Krishna Kumar; Syed Rizvi; Shivanand P. Lad; Liong Liem; Bengt Linderoth; S. Mackey; Gladstone McDowell
The Neuromodulation Appropriateness Consensus Committee (NACC) of the International Neuromodulation Society (INS) evaluated evidence regarding the safety and efficacy of neurostimulation to treat chronic pain, chronic critical limb ischemia, and refractory angina and recommended appropriate clinical applications.
Neuromodulation | 2012
Timothy R. Deer; Robert M. Levy; Joshua Prager; Eric Buchser; Allen W. Burton; David Caraway; Michael Cousins; José De Andrés; Sudhir Diwan; Michael A. Erdek; Eric Grigsby; Marc A. Huntoon; Marilyn S. Jacobs; Philip Kim; Krishna Kumar; Michael Leong; Liong Liem; Gladstone McDowell; Sunil Panchal; Richard Rauck; Michael Saulino; B. Todd Sitzman; Peter S. Staats; Michael Stanton-Hicks; Lisa Stearns; Mark S. Wallace; K. Dean Willis; William W. Witt; Tony L. Yaksh; Nagy Mekhail
Introduction: Targeted intrathecal drug infusion to treat moderate to severe chronic pain has become a standard part of treatment algorithms when more conservative options fail. This therapy is well established in the literature, has shown efficacy, and is an important tool for the treatment of both cancer and noncancer pain; however, it has become clear in recent years that intrathecal drug delivery is associated with risks for serious morbidity and mortality.
Neuromodulation | 2012
Timothy R. Deer; Joshua Prager; Robert M. Levy; Allen W. Burton; Eric Buchser; David Caraway; Michael Cousins; José De Andrés; Sudhir Diwan; Michael A. Erdek; Eric Grigsby; Marc A. Huntoon; Marilyn S. Jacobs; Phillip Kim; Krishna Kumar; Michael Leong; Liong Liem; Gladstone McDowell; Sunil Panchal; Richard Rauck; Michael Saulino; Peter S. Staats; Michael Stanton-Hicks; Lisa Stearns; B. Todd Sitzman; Mark S. Wallace; K. Dean Willis; William W. Witt; Tony L. Yaksh; Nagy Mekhail
Introduction: Trialing for intrathecal pump placement is an essential part of the decision‐making process in placing a permanent device. In both the United States and the international community, the proper method for trialing is ill defined.
Neuromodulation | 2012
Timothy R. Deer; Joshua Prager; Robert M. Levy; James P. Rathmell; Eric Buchser; Allen W. Burton; David Caraway; Michael Cousins; José De Andrés; Sudhir Diwan; Michael A. Erdek; Eric Grigsby; Marc A. Huntoon; Marilyn S. Jacobs; Philip Kim; Krishna Kumar; Michael Leong; Liong Liem; Gladstone McDowell; Sunil Panchal; Richard Rauck; Michael Saulino; B. Todd Sitzman; Peter S. Staats; Michael Stanton-Hicks; Lisa Stearns; Mark S. Wallace; K. Dean Willis; William W. Witt; Tony L. Yaksh
Introduction: Continuous intrathecal infusion of drugs to treat chronic pain and spasticity has become a standard part of the algorithm of care. The use of opioids has been associated with noninfectious inflammatory masses at the tip of the intrathecal catheter, which can result in neurologic complications.
Neuromodulation | 2017
Timothy R. Deer; Jason E. Pope; Salim M. Hayek; Anjum Bux; Eric Buchser; Sam Eldabe; José De Andrés; Michael A. Erdek; Dennis Patin; Jay S. Grider; Daniel M. Doleys; Marilyn S. Jacobs; Tony L. Yaksh; Lawrence Poree; Mark S. Wallace; Joshua Prager; Richard Rauck; Oscar DeLeon; Sudhir Diwan; Steven M. Falowski; Helena M. Gazelka; Philip Kim; Michael Leong; Robert M. Levy; Gladstone McDowell; Porter McRoberts; Ramana K. Naidu; Narouze S; Christophe Perruchoud; Steven M. Rosen
Pain treatment is best performed when a patient‐centric, safety‐based philosophy is used to determine an algorithmic process to guide care. Since 2007, the International Neuromodulation Society has organized a group of experts to evaluate evidence and create a Polyanalgesic Consensus Conference (PACC) to guide practice.
Pain Practice | 2013
Corey Hunter; Nimish Davé; Sudhir Diwan; Timothy R. Deer
Chronic pelvic pain (CPP) is complex and often resistant to treatment. While the exact pathophysiology is unknown, the pain states resultant from conditions such as interstitial cystitis and the like yield patients with a presentation that bears a striking similarity to neuropathic syndromes that are known to respond to neuromodulation. While there has been past success using the sacral region as a target for spinal cord stimulation (SCS) to treat these patients, there remains to be a consensus on the optimal location for lead placement. In this article, the authors discuss the potential etiology of CPP, examine the current literature on lead placement for SCS as a method of treatment, as well as present several cases where novel lead placement was successfully employed.
Neuromodulation | 2014
Timothy R. Deer; Nagy Mekhail; Erika A. Petersen; Elliot S. Krames; Peter S. Staats; Jason E. Pope; Youssef Saweris; Shivanand P. Lad; Sudhir Diwan; Steven M. Falowski; Claudio Feler; Konstantin V. Slavin; Samer Narouze; Lotfi B. Merabet; Asokumar Buvanendran; Felipe Fregni; Joshua Wellington; Robert M. Levy
The International Neuromodulation Society (INS) has identified a need for evaluation and analysis of the practice of neurostimulation of the brain and extracranial nerves of the head to treat chronic pain.
Current Pain and Headache Reports | 2014
Laxmaiah Manchikanti; Frank J. E. Falco; Sudhir Diwan; Joshua A. Hirsch; Howard S. Smith
Chronic neck pain and cervical radicular pain are relatively common in the adult population. Treatment for chronic radicular pain recalcitrant to conservative management includes surgical management as well as interventional techniques with epidural injections utilizing either an interlaminar approach or transforaminal approach. Although there have been multiple systematic reviews and randomized clinical trials of cervical interlaminar epidural injections, the literature is sparse in reference to cervical transforaminal epidural injections. Overall, there is good evidence for the effectiveness of cervical interlaminar epidural injections in managing cervical disc herniation and fair evidence in managing central spinal stenosis and postsurgery syndrome. The evidence is poor, however, for cervical transforaminal epidural injections. Complications with cervical interlaminar epidural injections are rare, but more commonly occur with transforaminal epidural injections and can be fatal. Emerging concepts in pain include further randomized trials; proper placebo design; focus on control design (either active control or placebo control); and appropriate methodologic quality assessment and evidence synthesis.